Healthcare - Medical - Devices - NASDAQ - US
$ 260.12
-0.398 %
$ 18.2 B
Market Cap
44.24
P/E
CASH FLOW STATEMENT
146 M
OPERATING CASH FLOW
-119 M
INVESTING CASH FLOW
-13.6 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Insulet Corporation
| Net Income | 206 M |
| Depreciation & Amortization | 72.8 M |
| Capital Expenditures | -75.6 M |
| Stock-Based Compensation | 48.3 M |
| Change in Working Capital | -191 M |
| Others | 37.1 M |
| Free Cash Flow | 36.5 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||||||
| Net Income | 206.3 | 4.6 | 16.8 | 6.8 | 11.6 | 3.3 | (26.8) | (28.9) | (73.5) | (51.5) | (45.0) | (51.9) | (57.2) | (61.2) | (79.5) | (92.8) | (53.5) | (36.0) | (21.6) | (13.8) |
| Depreciation & Amortization | 72.8 | 63.2 | 57.4 | 55.4 | 27.9 | 15.6 | 13.9 | 13.8 | 15.8 | 12.2 | 11.8 | 11.0 | 8.5 | 5.1 | 5.2 | 7.0 | 4.9 | 2.6 | 1.2 | 0.3 |
| Deferred Income Tax | 0 | 0 | 45.5 | 3.3 | 13.2 | 3.0 | 2.6 | 10.9 | 10.3 | 26.5 | 7.3 | 3.4 | 67.5 | 17.7 | 11.6 | (3.4) | (1.5) | 0 | 0 | 0 |
| Stock Based Compensation | 48.3 | 40.9 | 34.4 | 35.9 | 28.7 | 37.5 | 31.9 | 23.6 | 19.2 | 22.5 | 12.7 | 9.9 | 7.7 | 5.1 | 4.2 | 3.4 | 1.5 | 0 | 0 | 0 |
| Other Operating Activities | 8.9 | 12.8 | 41.4 | 46.0 | 36.7 | 29.3 | 18.0 | 10.1 | 7.7 | 10.3 | 10.1 | 10.2 | (54.6) | 5.1 | 6.9 | 16.8 | 3.8 | 2.1 | 53 K | 85 K |
| Change in Working Capital | (190.6) | (2.5) | (263.6) | (63.4) | (19.7) | (52.8) | 1.6 | (13.6) | 8.0 | (11.0) | 6.5 | (11.8) | 2.6 | (7.4) | 2.3 | (13.6) | (5.5) | (0.6) | 26 K | 0.4 |
| Cash From Operations | 145.7 | 119.0 | (68.1) | 84.0 | 98.4 | 35.9 | 41.2 | 15.9 | (12.6) | 8.9 | 3.3 | (29.1) | (25.5) | (35.6) | (49.3) | (82.6) | (50.4) | (31.8) | (20.3) | (13.1) |
| INVESTING CASH FLOW | ||||||||||||||||||||
| Capital Expenditures | (75.6) | (157.3) | (122.7) | (166.5) | (170.9) | (162.4) | (77.2) | (22.1) | (10.6) | (11.5) | (7.3) | (11.0) | (11.1) | (6.5) | (3.1) | (10.0) | (10.1) | (13.1) | (5.5) | (2.7) |
| Other Items | (43.8) | (33.8) | 40.0 | 180.5 | 97.3 | (22.1) | (133.6) | (155.9) | (4.7) | 0 | 0 | 0 | (37.9) | 0 | 0 | 0 | 0 | 0.6 | (0.6) | 0 |
| Cash From Investing Activities | (119.4) | (191.1) | (82.7) | 14.0 | (73.6) | (184.5) | (210.8) | (178.0) | (15.3) | (11.5) | (7.3) | (11.0) | (49.0) | (6.5) | (3.1) | (10.0) | (10.1) | (12.6) | (6.0) | (2.7) |
| FINANCING CASH FLOW | ||||||||||||||||||||
| Common Stock Repurchased | 10.6 | (16.8) | (28.2) | 0 | (8.6) | (17.8) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (27.0) | (39.8) | 49.4 | 126.6 | 116.6 | (6.7) | 292.8 | 174.6 | (5.6) | 1.1 | (3.0) | 0 | 50.6 | (33.0) | 29.4 | 53.3 | (2.7) | 20.0 | 10.0 | 11 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (13.5) | (0.5) | (8.7) | 1.4 | (8.6) | (2.0) | (4.1) | (2.9) | (2.6) | (8.7) | (3.3) | (1.5) | (0.9) | 11.7 | 0 | 0 | 10 K | 11 K | 0 | 0 |
| Cash From Financing Activities | (13.6) | (40.3) | 40.7 | 605.5 | 73.5 | (8.7) | 304.5 | 176.6 | (0.4) | 4.0 | 96.4 | 3.4 | 55.1 | 27.5 | 123.8 | 54.7 | 121.8 | 70.0 | 10.0 | 35.4 |
| CHANGE IN CASH | ||||||||||||||||||||
| Net Change In Cash | 14.5 | (116.7) | (115.6) | 708.3 | 99.8 | (158.7) | 135.4 | 14.5 | (28.5) | 1.5 | 92.4 | (36.7) | (19.3) | (14.7) | 71.3 | (37.9) | 61.4 | 25.6 | (16.3) | 19.7 |
| FREE CASH FLOW | ||||||||||||||||||||
| Free Cash Flow | 36.5 | (38.3) | (190.8) | (82.5) | (72.5) | (126.5) | (36.0) | (6.2) | (23.2) | (2.6) | (4.0) | (40.0) | (36.6) | (42.2) | (52.5) | (92.7) | (60.5) | (45.0) | (25.8) | (15.8) |